Disruptive Technology: CRISPR/Cas-Based Tools and Approaches

por Patsali, Petros, Kleanthous, Marina, Lederer, Carsten W.
Publicado 2019

Relative and Absolute Quantification of Aberrant and Normal Splice Variants in HBB(IVSI−110 (G > A)) β-Thalassemia

por Patsali, Petros, Papasavva, Panayiota, Christou, Soteroulla, Sitarou, Maria, Antoniou, Michael N., Lederer, Carsten W., Kleanthous, Marina
Publicado 2020

CRISPR Editing Enables Consequential Tag-Activated MicroRNA-Mediated Endogene Deactivation

por Papasavva, Panayiota L., Patsali, Petros, Loucari, Constantinos C., Kurita, Ryo, Nakamura, Yukio, Kleanthous, Marina, Lederer, Carsten W.
Publicado 2022

Distinct miRNA Signatures and Networks Discern Fetal from Adult Erythroid Differentiation and Primary from Immortalized Erythroid Cells

por Papasavva, Panayiota L., Papaioannou, Nikoletta Y., Patsali, Petros, Kurita, Ryo, Nakamura, Yukio, Sitarou, Maria, Christou, Soteroulla, Kleanthous, Marina, Lederer, Carsten W.
Publicado 2021

The Scope for Thalassemia Gene Therapy by Disruption of Aberrant Regulatory Elements

por Patsali, Petros, Mussolino, Claudio, Ladas, Petros, Floga, Argyro, Kolnagou, Annita, Christou, Soteroula, Sitarou, Maria, Antoniou, Michael N., Cathomen, Toni, Lederer, Carsten Werner, Kleanthous, Marina
Publicado 2019

High-efficiency editing in hematopoietic stem cells and the HUDEP-2 cell line based on in vitro mRNA synthesis

por Papaioannou, Nikoletta Y., Patsali, Petros, Naiisseh, Basma, Papasavva, Panayiota L., Koniali, Lola, Kurita, Ryo, Nakamura, Yukio, Christou, Soteroula, Sitarou, Maria, Mussolino, Claudio, Cathomen, Toni, Kleanthous, Marina, Lederer, Carsten W.
Publicado 2023

Rapid and Sensitive Assessment of Globin Chains for Gene and Cell Therapy of Hemoglobinopathies

por Loucari, Constantinos C., Patsali, Petros, van Dijk, Thamar B., Stephanou, Coralea, Papasavva, Panayiota, Zanti, Maria, Kurita, Ryo, Nakamura, Yukio, Christou, Soteroulla, Sitarou, Maria, Philipsen, Sjaak, Lederer, Carsten W., Kleanthous, Marina
Publicado 2018